Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

News, archive: September 2018

9/28/2018 Database Update: Pharmaceutical Drug Production in Russia (August 2018)

Between January and August 2018, Russia produced 212.8 bln RUB worth of pharmaceutical drugs (dispatch prices, VAT included), which is in monetary terms only 0.1% higher than that of the same period of 2017. In physical terms, Russia produced 2.61 bln units. The dynamics are -10.4%, which have been gradually decreasing for 10 months.

9/6/2018 Rating of Russian Pharmacy Chains (Q1 – Q2 2018)

On the one hand, the first six months of 2018 for the Russian pharmaceutical retail was marked by a slight recovery in demand, which, despite failing to bring the segment out of the red zone, promised some growth by the end of the year, unless the macroeconomic situation changes.